Abstract | BACKGROUND: AIMS: METHODS: RESULTS: Overall median survival time was 190 days (30-856). Forty-four patients (62.8%) died after median 175.5 days (30-614) without signs of stent dysfunction; 37 patients (52.8%) were alive after 6 months without signs of self-expandable metal stents occlusion. Survival rapidly dropped between 8 and 12 months after treatment. Survival was not influenced by sex (P = 0.1) or type of neoplasia (P = 0.178). Median survival was longer (254 days [44-836]) in patients who underwent chemotherapy (P < 0.0001). Partially covered self-expandable metal stents occlusion had 24 (35.7%) patients 154 days (35-485) after treatment. Median survival after re-treatment was 66 days (13-597). Cholecystitis occurred in one patient (1.7%). CONCLUSIONS:
|
Authors | Vincenzo Perri, Ivo Boškoski, Andrea Tringali, Pietro Familiari, Michele Marchese, Dong Ki Lee, Sung Il Jang, Jimin Han, Ho Gak Kim, Massimiliano Mutignani, Graziano Onder, Guido Costamagna |
Journal | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
(Dig Liver Dis)
Vol. 45
Issue 4
Pg. 305-9
(Apr 2013)
ISSN: 1878-3562 [Electronic] Netherlands |
PMID | 23218991
(Publication Type: Clinical Trial, Journal Article, Multicenter Study)
|
Copyright | Copyright © 2012 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved. |
Chemical References |
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Alloys
- Bilirubin
(blood)
- Cholangiopancreatography, Endoscopic Retrograde
- Cholestasis
(blood, etiology, surgery)
- Female
- Follow-Up Studies
- Humans
- Logistic Models
- Male
- Middle Aged
- Multivariate Analysis
- Neoplasms
(complications)
- Palliative Care
- Proportional Hazards Models
- Stents
(adverse effects)
|